Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X6XF
|
|||
| Former ID |
DIB016882
|
|||
| Drug Name |
VTP-201227
|
|||
| Indication | Psoriatic disorder [ICD-11: EA90; ICD-9: 696] | Discontinued in Phase 2 | [1] | |
| Company |
Vitae Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cytochrome P450 reductase (P450) | Target Info | Inhibitor | [2] |
| BioCyc | Superpathway of tryptophan utilization | |||
| Superpathway of melatonin degradation | ||||
| Melatonin degradation I | ||||
| Vitamin D<sub>3</sub> biosynthesis | ||||
| Bile acid biosynthesis, neutral pathway | ||||
| WikiPathways | Oxidation by Cytochrome P450 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022961) | |||
| REF 2 | VTP-201227. VietMedix. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.